Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INS365 (Diquafosol) Phase 3 Study in Dry Eye Disease
NCT00404131Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Mar 2001
- Primary completion
- Dec 2001
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of diquafosol in dry eye disease (DED), sponsored by Merck & Co.. Started Mar 2001; status: completed.
02
Drugs
diquafosol
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT00404131.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00404131.